BGM BGM Group Corp Company Net Income

Official company branding of BGM Group Ltd (BGM)

BGM Group Ltd profit levels confirm the resilience of a business protected by patents and rigorous testing standards. The value of -0.02 shows the latest figure for this metric. Revenues are based on the implementation of targeted therapy and small-molecule drugs for the treatment of rare pathologies. Financial stability relies on the contract manufacturing of complex drugs and international partnerships in the generics segment.

BGM BGM Group Net Income (08/13/2024 - 11/01/2026)

Financial and market metric breakdowns for bgm.ltd (BGM)

- market value and analyst target forecast:
Stock Price BGM Group|BGM - Price Target Chart
- market capitalization data:
Market Value BGM Group Corp|BGM - Enterprise Value
- book capitalization indicators:
Net Assets per Share BGM Group|BGM - Company Net Assets|Market Capitalization to Net Assets bgm.ltd|BGM - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital BGM Group Ltd|BGM - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio BGM Group|BGM - Company Total Debt|Debt to Net Assets Ratio BGM Group Corp|BGM - Company Long-Term Debt|Current Liabilities BGM Group|Intermediate Coverage Ratio bgm.ltd
- earnings and multiples data:
BGM - Net Profit
Summary company analysis:BGM Group Corp (BGM)
Signature product of BGM Group Corp

This indicator measures the business's net financial result in real time, allowing for the exclusion of accounting manipulations and an assessment of the enterprise's organic viability. By analyzing the company's current profit levels, an investor can diagnose the stability of BGM Group Ltd. during the pre-commercial testing phase of highly specialized drugs, determining the capital's readiness for a future entry into niche medical segments.

Main competitors

Vertex Corp (VRTX) - Net Profit|Company Net Income Alnylam Pharmaceuticals|Company Net Income INSM|Net Profit UTHR|Net Financial Result BioMarin Pharmaceutical Inc.|BridgeBio Pharma Inc - Net Income|COGT (Cogent Corp) - Profit After Tax|Xeris Biopharma - Net Profit|Company Net Income kerostx.com|ARCT: Net Profit|Company Profit ETON|Net Income KMDA|FULC: Final Profit|Company Net Income Abeona Therapeutics (ABEO)|MREO: Profit After Tax|Net Profit PLX (Protalix BioTherapeutics, Inc.)|Final Profit PLRX|Applied Therapeutics, Inc. - Net Profit|RNTX - Net Profit|gelteq.com (GELS) - Company Net Income|Aytu BioPharma - Final Profit|Company Net Income Chemomab Therapeutics Ltd|Net Income SRx Health (SRXH)|Net Profit PLRZ|Net Profit zentaris.com (AEZS)|Net Profit CYTH (Cyclo Therapeutics)|Inozyme Pharma Inc. - Company Net Income|Reneo Pharmaceuticals, Inc. - Net Profit|Annual Net Income COSCIENS Biopharma Inc (CSCI)